Global Metabolomics Market to Reach $8.1 Billion by 2030
The global market for Metabolomics estimated at US$1.9 Billion in the year 2022, is projected to reach a revised size of US$8.1 Billion by 2030, growing at a CAGR of 19.9% over the analysis period 2022-2030. Biomarker Discovery, one of the segments analyzed in the report, is projected to record 22.1% CAGR and reach US$3.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Drug Discovery segment is readjusted to a revised 19.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $554.7 Million, While China is Forecast to Grow at 19% CAGR
The Metabolomics market in the U.S. is estimated at US$554.7 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 19% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.7% and 16.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.4% CAGR.Select Competitors (Total 31 Featured) -
- AB Sciex LLC
- African Biosciences Ltd
- Agilent Technologies, Inc.
- Agios Pharmaceuticals, Inc.
- Berg LLC
- BioCat GmbH
- Biocenter Finland
- Biocrates Life Sciences AG
- Biogenetics
- Bio-Rad Laboratories, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Sciex LLC
- African Biosciences Ltd
- Agilent Technologies, Inc.
- Agios Pharmaceuticals, Inc.
- Berg LLC
- BioCat GmbH
- Biocenter Finland
- Biocrates Life Sciences AG
- Biogenetics
- Bio-Rad Laboratories, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 268 |
Published | April 2024 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 2.2 Billion |
Forecasted Market Value ( USD | $ 5 Billion |
Compound Annual Growth Rate | 12.4% |
Regions Covered | Global |